赢8娱乐糖果配对游戏-官方网站[welcome]


+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Perioperative Antimicrobial Prophylaxis for Preventing Infectious Complications After Transurethral Resection of the Bladder: To Use or Not to Use?



Perioperative Antimicrobial Prophylaxis for Preventing Infectious Complications After Transurethral Resection of the Bladder: To Use or Not to Use?



Journal of Endourology 34(2): 198-202



Purpose: Transurethral resection of the bladder (TURB) is a common endoscopic procedure. Perioperative antimicrobial prophylaxis (AMP) is used to reduce the risk of infectious complications. However, there is an absence of knowledge about both incidence of infectious complications after TURB and advantage of AMP in general. The objective of this study is to determinate the prevalence of postoperative infectious complications after routine TURB without AMP. Methods: We retrospectively reviewed clinical data of all patients who underwent TURB in the same Academic Urologic Department between January 2011 and December 2013. We consider as relevant for analysis, patients that underwent TURB without receiving any AMP. Infection was defined as a body temperature >37.5°C sustained for at least 24 hours. Sepsis was defined according to the third international consensus definition for sepsis and septic shock. Results: In the period of the study, 223 TURBs were performed without use of AMP. Mean age was 70.3 years (standard deviation [SD] 11.3). Mean operative time was 25.14 minutes (SD 16). Median length of hospital stay was 3 days (interquartile range [IQR]: 2-4). Six (2.7%) patients developed postoperative infective complications. No case of sepsis was reported. Two (0.9%) patients received an antimicrobial therapy with fluoroquinolones despite absence of any signs of infection. Two hundred fifteen (96.4%) patients of TURBs did not receive any antimicrobial drugs and did not develop any infectious complications. Conclusion: In our series, infectious complications after TURB occurred in <3% of cases. In conclusion AMP should not be routinely used prior TURB.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 069547569

Download citation: RISBibTeXText

PMID: 31760786


Related references

Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study. International Journal of Urology 16(1): 61-63, 2009

Perioperative antimicrobial therapy in preventing infectious complications following pancreatoduodenectomy. Indian Journal of Medical Research 146(4): 514-519, 2017

Perioperative complications of transurethral resection of bladder tumor in patients receiving antithrombotic therapy. Hinyokika Kiyo. Acta Urologica Japonica 60(11): 531-535, 2014

Ten-Year Review of Perioperative Complications After Transurethral Resection of Bladder Tumors: Analysis of Monopolar and Plasmakinetic Bipolar Cases. Journal of Endourology 31(8): 767-773, 2017

Transurethral resection with perioperative instillation of interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: A prospective randomized multicenter study-Finnbladder III. Journal of Urology 161(4): 1133-1136, 1999

The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy. Urologic Oncology 34(3): 121.E9, 2016

Perioperative Single Dose Instillation of Epirubicin or Interferon- After Transurethral Resection for The Prophylaxis of Primary Superficial Bladder Cancer Recurrence: A Prospective Randomized Multicenter StudyFinnbladder Iii Long-Term Results. The Journal of Urology 168(3): 981-985, 2002

Antimicrobial prophylaxis for transurethral resection of bladder tumor: A retrospective comparison of preoperative single-dose administration of piperacillin and tazobactam/piperacillin. Journal of Infection and ChemoTherapy 24(12): 954-957, 2018

Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study--FinnBladder III long-term results. Journal of Urology 168(3): 981-985, 2002

Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study - Finnbladder III long-term results. International Braz J Urol 28(5): 489-490, 2002

Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study. Clinical Genitourinary Cancer 15(1): 157-162, 2017

Perioperative antibiotic prophylaxis for transurethral resection of the prostate: is it justifiable?. Journal of Urology 142(2 Pt 1): 317-319, 1989

Outcome of simultaneous transurethral resection of bladder tumor and transurethral resection of the prostate in comparison with the procedures in two separate sittings in patients with bladder tumor and urodynamically proven bladder outflow obstruction. Journal of Endourology 23(12): 2007-2011, 2009

A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: Transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Journal of Urology 156(3): 962-966, 1996

Antimicrobial prophylaxis in transurethral resection of the prostate. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 89(4): 453-459, 1998





赢8娱乐糖果配对游戏